SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that on September 18, 2023, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted an inducement award consisting of a non-qualified stock option to purchase 106,000 shares of common stock to…Read More
Bionano Genomics Bionano Reports Inducement Grant Under Nasdaq Listing Rule 5635c4
